Priscila Pineda-Villegas

Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.

B. Ortiz-Quintero, O. Arrieta, Z. Zatarain-Barrón, 2021, European journal of cancer.